Literature DB >> 26248830

N-of-1 trials in oncology.

Laurence Collette1, Bertrand Tombal2.   

Abstract

Mesh：

Year:  2015        PMID： 26248830     DOI： 10.1016/S1470-2045(15)00062-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.

Authors:  Rohith Srivas; John Paul Shen; Chih Cheng Yang; Su Ming Sun; Jianfeng Li; Andrew M Gross; James Jensen; Katherine Licon; Ana Bojorquez-Gomez; Kristin Klepper; Justin Huang; Daniel Pekin; Jia L Xu; Huwate Yeerna; Vignesh Sivaganesh; Leonie Kollenstart; Haico van Attikum; Pedro Aza-Blanc; Robert W Sobol; Trey Ideker
Journal:  Mol Cell       Date:  2016-07-21       Impact factor: 17.970

2.  Pragmatic medicine in solid cancer: a translational alternative to precision medicine.

Authors:  Jan Brábek; Daniel Rosel; Michael Fernandes
Journal:  Onco Targets Ther       Date:  2016-04-05       Impact factor: 4.147

Review 3.  Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.

Authors:  Peter Horak; Stefan Fröhling; Hanno Glimm
Journal:  ESMO Open       Date:  2016-11-18

Review 4.  Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?

Authors:  Elisabetta Rossi; Rita Zamarchi
Journal:  Front Genet       Date:  2019-10-17       Impact factor: 4.599

5.  Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases.

Authors:  Miguel Sampayo-Cordero; Bernat Miguel-Huguet; Almudena Pardo-Mateos; Andrea Malfettone; José Pérez-García; Antonio Llombart-Cussac; Javier Cortés; Marc Moltó-Abad; Cecilia Muñoz-Delgado; Marta Pérez-Quintana; Jordi Pérez-López
Journal:  Orphanet J Rare Dis       Date:  2019-10-21       Impact factor: 4.123

6.  Matching methods in precision oncology: An introduction and illustrative example.

Authors:  Deirdre Weymann; Janessa Laskin; Steven J M Jones; Howard Lim; Daniel J Renouf; Robyn Roscoe; Kasmintan A Schrader; Sophie Sun; Stephen Yip; Marco A Marra; Dean A Regier
Journal:  Mol Genet Genomic Med       Date:  2020-11-25       Impact factor: 2.183

7.  An analysis of common ethical justifications for compassionate use programs for experimental drugs.

Authors:  Kasper Raus
Journal:  BMC Med Ethics       Date:  2016-10-18       Impact factor: 2.652
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.